Hirohito Yamaguchi
China Medical University
H-index: 51
Asia-China
Top articles of Hirohito Yamaguchi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer | International Journal of Biological Sciences | Hirohito Yamaguchi Ling-Chu Chang Olin Shih-Shin Chang Yu-Fu Chen Yu-Chun Hsiao | 2024 |
Post-translational Modification of PD-1: Potential Pathways for Cancer Immunotherapy | Te-An Lee En-Yun Tsai Shou-Hou Liu Shih-Duo Hsu Hung Shing-Jyh Chang | 2024/1/17 | |
Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry | Biomedicines | Shaneek Natoya Dabrell Yi-Chuan Li Hirohito Yamaguchi Hsiao-Fan Chen Mien-Chie Hung | 2023/10/27 |
PD-L1 and CD58 co-regulated by CMTM6 play yin and yang to shape anti-tumor immunity | Cancer Cell | Hirohito Yamaguchi Mien-Chie Hung | 2023/10/9 |
Prospects of the potential strategies to improve the efficacy of anti‐PD‐1/PD‐L1 therapy | Clinical and Translational Medicine | Hirohito Yamaguchi Shao‐Chun Wang Mien‐Chie Hung | 2022/5 |
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics | Hirohito Yamaguchi Jung-Mao Hsu Wen-Hao Yang Mien-Chie Hung | 2022/2/7 | |
Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates | Parham Jabbarzadeh Kaboli Shima Shabani Sagar Sharma Minoo Partovi Nasr Hirohito Yamaguchi | 2022 | |
Structural insights into EphA4 unconventional activation from prediction of the EphA4 and its complex with ribonuclease 1 | American Journal of Cancer Research | Yi-Chuan Li Hirohito Yamaguchi Yen-Yi Liu Kai-Cheng Hsu Ting-Hsuan Sun | 2022 |
Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors | Yu-Yi Chu Clinton Yam Hirohito Yamaguchi Mien-Chie Hung | 2022/12 | |
Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex | Nature Cancer | Yu-Yi Chu Mei-Kuang Chen Yongkun Wei Heng-Huan Lee Weiya Xia | 2022/10 |
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis | Journal of Clinical Investigation | Zhou Jiang Seung-Oe Lim Meisi Yan Jennifer L Hsu Jun Yao | 2021/4/15 |
Estrogen promotes increased breast cancer cell proliferation and migration through downregulation of CPEB1 expression | Biochemical and biophysical research communications | Watcharee Sovijit Watcharin Sovijit Yuriko Ishii Jun Kambe Tomoyuki Fujita | 2021/1/1 |
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation | Nature communications | Heng-Huan Lee Ying-Nai Wang Wen-Hao Yang Weiya Xia Yongkun Wei | 2021/5/13 |
A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations | Frontiers in Oncology | Hirohito Yamaguchi Ghina M Taouk | 2020/6/11 |
Isolation of cancer-derived extracellular vesicle subpopulations by a size-selective microfluidic platform | Biomicrofluidics | Zheyuan Chen Yi Yang Hirohito Yamaguchi Mien-Chi Hung Jun Kameoka | 2020/5/8 |
Heat-killed Enterococcus fecalis (EC-12) supplement alters the expression of neurotransmitter receptor genes in the prefrontal cortex and alleviates anxiety-like behavior in mice | Neuroscience Letters | Jun Kambe Sovijit Watcharin Yuko Makioka-Itaya Ryo Inoue Gen Watanabe | 2020/1/10 |
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer | American Journal of Cancer Research | Yu-Yi Chu Clinton Yam Mei-Kuang Chen Li-Chuan Chan Min Xiao | 2020 |
